Medipol: the guardian angel of biologics.
Medipol Ltd is a solution provider to the pharma, medtech and biotech industry. It helps these companies to improve their management of the lifecycle of biotechnological drugs and maintain market leadership through the protection and delivery of biologics in medical applications. The company was incorporated in May 2003 in Lausanne, Switzerland. Medipol's management and researchers are credited with decades of experience in the application of biopolymers and are authors of more than 30 patents in the field. Medipol's current focus is rheumatoid arthritis and the delivery of biopharmaceuticals. The company has been rewarded for its pioneering technology by the Foundation for Innovation and Technology, the IMD business school, the Swiss Commission for Innovation and Technology and Venture Leaders 2006.
Laue
Carsten
C
Medipol Ltd., PSE-B, Lausanne, Switzerland. carsten.laue@medipol.ch
Ruppanner
Violette
V
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001688:Biological Products / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D001709:Biotechnology / Q000379:methods* / Q000458:organization & administration / Q000639:trends; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D009936:Organizational Innovation; D013557:Switzerland; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000458:organization & administration / Q000639:trends
D001688:Biological Products